Molecular basis of the enhanced susceptibility of the erythrocytes of paroxysmal nocturnal hemoglobinuria to hemolysis in acidified serum
Wilcox LA, Ezzell JL, Bernshaw NJ, et al. Molecular basis of the enhanced susceptibility of the erythrocytes of paroxysmal nocturnal hemoglobinuria to hemolysis in acidified serum. Blood. 1991;78:820-829.
Deficiency of glycosyl phosphatidylinositol-anchored proteins in polymorphonuclear leukocytes from patients with paroxysmal nocturnal hemoglobinuria with low-grade hemolysis
Shibuya K, Ninomiya H, Muraki Y, et al. Deficiency of glycosyl phosphatidylinositol-anchored proteins in polymorphonuclear leukocytes from patients with paroxysmal nocturnal hemoglobinuria with low-grade hemolysis. Int J Hematol. 1993; 58:15-20.
The use of monoclonal antibodies and flow cytometry in the diagnosis of paroxysmal nocturnal hemoglobinuria
Hall SE, Rosse WF. The use of monoclonal antibodies and flow cytometry in the diagnosis of paroxysmal nocturnal hemoglobinuria. Blood 1996;87:5332-5340.
Markedly high population of affected reticulocytes negative for decay-accelerating factor and CD59 in paroxysmal nocturnal hemoglobinuria
Iwamoto N, Kawaguchi T, Nagakura S, et al. Markedly high population of affected reticulocytes negative for decay-accelerating factor and CD59 in paroxysmal nocturnal hemoglobinuria. Blood. 1995;85:2228-2232.
Investigation of the survival of paroxysmal nocturnal hemoglobinuria red cells through the immunophenotyping of reticulocytes
Navenot JM, Muller JY, Blanchard D. Investigation of the survival of paroxysmal nocturnal hemoglobinuria red cells through the immunophenotyping of reticulocytes. Transfusion. 1998;38: 337-342.
Pseudoreticulocytosis in a patient with hemoglobin Köln due to autofluorescent erythrocytes enumerated as reticulocytes by the Cell-Dyn 4000
Sato S, Hirayama K, Koyama A, et al. Pseudoreticulocytosis in a patient with hemoglobin Köln due to autofluorescent erythrocytes enumerated as reticulocytes by the Cell-Dyn 4000. Lab Hematol. 2004;10:65-67.
The complement-inhibitory activity of the human erythrocyte membrane homologous restriction factor. Binding of CD59 to the alpha subunit of C8 and the "b" domain of C9
Ninomiya H, Sims PJ. The complement-inhibitory activity of the human erythrocyte membrane homologous restriction factor. Binding of CD59 to the alpha subunit of C8 and the "b" domain of C9. J Biol Chem. 1992;267:13675-13680.